Ensysce Biosciences's total assets for Q2 2024 were $2.80M, a decrease of -44.91% from the previous quarter. ENSC total liabilities were $1.32M for the fiscal quarter, a -20.40% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.